You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alpha 2 delta ligands

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

COVID-19 Pandemic Trial in China (SCTV01E, Placebo (normal saline))

Recruiting
  • COVID-19 Pandemic
  • SCTV01E
  • Placebo (normal saline)
  • Lianshui, Jiangsu, China
  • +3 more
Jan 5, 2023

COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)

Not yet recruiting
  • COVID-19 SARS-CoV-2 Infection
  • CoronaVac
  • SCTV01E
  • (no location specified)
Jan 4, 2023

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Clinical Features Associated With Restless Legs Syndrome.

Recruiting
  • Restless Legs Syndrome
    • Montpellier, France
      Uhmontpellier
    Sep 18, 2021

    COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, mRNA vaccine manufactured by Pfizer or Moderna)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • SCTV01C
    • +3 more
    • (no location specified)
    Apr 1, 2022

    DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

    Recruiting
    • Diffuse Large B-Cell Lymphoma
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 12, 2022

    B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

    Recruiting
    • B Acute Lymphoblastic Leukemia
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 16, 2022

    COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, mRNA-1273)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • SCTV01E
    • mRNA-1273
    • (no location specified)
    Apr 25, 2022

    SARS-CoV-2 Infection, COVID-19 Trial (SCTV01E, Comirnaty)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • COVID-19
    • SCTV01E
    • Comirnaty
    • (no location specified)
    Apr 11, 2022

    COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • SCTV01C
    • +3 more
    • (no location specified)
    Apr 1, 2022

    COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • SCTV01C
    • +3 more
    • (no location specified)
    Apr 10, 2022

    COVID-19, Sars-CoV-2 Infection Trial (SCTV01E, Comirnaty)

    Not yet recruiting
    • COVID-19
    • Sars-CoV-2 Infection
    • SCTV01E
    • Comirnaty
    • (no location specified)
    Feb 14, 2022

    COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, CoronaVac, Sinopharm inactivated COVID-19 vaccine)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • SCTV01E
    • +3 more
    • (no location specified)
    Apr 1, 2022

    T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

    Recruiting
    • T Acute Lymphoblastic Leukemia
    • T Lymphoblastic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 11, 2023

    Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

    Recruiting
    • Acute Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Atlanta, Georgia
    • +13 more
    Jan 26, 2023

    Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

    Completed
    Has Results
    • Anaplastic Large Cell Lymphoma, ALK-Negative
    • +9 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +8 more
    • Duarte, California
    • +7 more
    Nov 4, 2022

    DLBCL Trial in Houston (Acalabrutinib, Cyclophosphamide, Doxorubicin Hydrochloride)

    Recruiting
    • Diffuse Large B-Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 10, 2022

    Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

    Recruiting
    • Mantle Cell Lymphoma
    • New Orleans, Louisiana
    • +5 more
    Dec 13, 2022

    B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

    Recruiting
    • B Acute Lymphoblastic Leukemia
    • Ph-Like Acute Lymphoblastic Leukemia
    • Duarte, California
      City of Hope Medical Center
    Jul 26, 2022

    DLBCL Unclassifiable Trial in Houston (Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide)

    Active, not recruiting
    • Diffuse Large B-Cell Lymphoma Unclassifiable
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 23, 2022

    Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II

    Active, not recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +13 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Aug 18, 2022

    Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

    Recruiting
    • Recurrent B Acute Lymphoblastic Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 2, 2022